InvestingEstrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas by TheCompaniesMay 29, 20250 Share0 Facebook Twitter Google+ Pinterest Amazon reddit LinkedIn Myspace
